Stay updated with breaking news from Greg Madison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) CEO Greg Madison speaks to Thomas Warner after a busy week for the commercial stage pharmaceutical company,...
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) CEO Greg Madison speaks to Thomas Warner after a busy week for the commercial stage pharmaceutical company,...
Proactive Research Analyst Robin Davison speaks to Thomas Warner after publishing a new research note on iron defiency-focused commercial-stage specialty...
Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) is raising up to US$27.5 million of new funds to support its development of Accrufer, its iron deficiency...
Shield Therapeutics PLC on Thursday announced steps to improve its financial situation, as it revealed a slightly reduced loss in the first half of 2023. Shield confirmed the subscription and placing...